Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 9, 2021
Patent Application Number
16241851
Date Filed
January 7, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
